To survive in the human host, bacteria have developed many different strategies to escape the innate immune response, including the expression of an extracellular capsule and 'hiding' within host ...

Wall Street initiates Quantinuum with Buy/Outperform calls, citing Helios traction and Apollo fault-tolerant roadmap plus big ...

Sanofi is halting the phase 3 MOBILIZE trial evaluating riliprubart for chronic inflammatory demyelinating polyneuropathy due to lack of efficacy.

For those who demand both artistic expression and aesthetic sensibility from their home technology, the search officially ...

Quantinuum stock rips higher as Wall Street analysts assign bullish price targets after the post-IPO quiet period. Here’s how ...

Overview: IBM has set a concrete deadline for quantum advantage, and IonQ already delivered a real-world win in ...

Recently published Chronic Inflammatory Demyelinating Polyneuropathy Market Insights report includes a comprehensive understanding of current treatment practices, chronic inflammatory demyelinating ...

Meeting the increasingly important but complex needs of the energy industry requires not only excellent design and engineering, but also advanced sensor capabilities that extend beyond the limits of ...

Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today announced that the riliprubart MOBILIZE phase ...

After nearly three years of whispers and possibilities, Costco officially announced its intention to build a ...

Elections keep handing power to elites. Anand Gopal and Ben Burgis debate whether choosing officials by lottery, as ancient Athens did, would be an improvement on representative democracy.